Antibiotic Receipt During Outpatient Visits for COVID-19 in the US, From 2020 to 2022-Reference-Cited by-同舟云学术

Antibiotic Receipt During Outpatient Visits for COVID-19 in the US, From 2020 to 2022

Published:2023-02-17 Issue:2 Volume:4 Page:e225429
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Wittman Samuel R.¹,Martin Judith M.¹,Mehrotra Ateev²,Ray Kristin N.¹

Affiliation:

1. Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania

2. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts

Abstract

This cross-sectional study examines prescribed and filled antibiotics for outpatient COVID-19 treatment among children, adolescents, and adults with commercial insurance.

Publisher

American Medical Association (AMA)

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2801478/wittman_2023_ld_220043_1675723772.34447.pdf

Reference6 articles.

1. Antibiotic prescriptions associated with COVID-19 outpatient visits among Medicare beneficiaries, April 2020 to April 2021.;Tsay;JAMA,2022

2. Reducing antibiotic prescribing in primary care for respiratory illness.;Kronman;Pediatrics,2020

3. Patient and family factors associated with use of telemedicine visits for pediatric acute respiratory tract infections, 2018-2019.;Wittman;Telemed J E Health,2022

4. Azithromycin in patients with COVID-19: a systematic review and meta-analysis.;Ayerbe;J Antimicrob Chemother,2022

5. COVID-19 and antibiotic prescribing in pediatric primary care.;Dutcher;Pediatrics,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016–2021 Data;Clinical Infectious Diseases;2024-04-22

2. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections;Clinical Microbiology and Infection;2024-04

3. Antibiotic Receipt for Pediatric Telemedicine Visits With Primary Care vs Direct-to-Consumer Vendors;JAMA Network Open;2024-03-14

4. Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic;eLife;2024-03-07

5. Effect of the COVID-19 pandemic on the pediatric infectious disease landscape;European Journal of Pediatrics;2023-09-20